Berberine inhibits phagocytosis through the TLR4-PI3K-CDC42 pathway

Abstract

Phagocytosis is a fundamental mechanism used by the body to resist pathogens and restore physiological homeostasis. Herein, to identify small molecules with anti-inflammatory properties via phagocytosis inhibition, we constructed a library of natural products and evaluated their ability to modulate phagocytosis in RAW264.7 macrophages. Berberine (BBR) is the major constituent of traditional Chinese medicine Coptidis Rhizoma that is recorded in Chinese Pharmacopoeia with the effect of clearing heat-toxin, and is used in the therapeutic management of various inflammatory diseases. BBR was found to inhibit phagocytosis and significantly alleviate inflammation via suppressing interleukin-1α (IL-1α), interleukin-1β (IL-1β), inducible nitric oxide synthase (iNOS), and tumor necrosis factor-α (TNF-α), according to real-time quantitative polymerase chain reaction (RT-qPCR) analyses, and phosphorylated-p65 (p-p65), iNOS, and cyclooxygenase-2 (COX-2), according to western blot analyses. BBR inhibited the expression of F-actin, a key protein in phagosome formation. Notably, BBR exerted its phagocytosis effects through targeting phosphoinositide 3-kinase (PI3K), thereby activating the small GTPase-Cdc42 (CDC42), Wiskott-Aldrich syndrome protein (WASP), and actin-related protein 2/3 complex subunit 2 (Arp2/3). BBR attenuated LPS-mediated inflammation through promoting macrophage phagocytosis. We determined that BBR targets the toll-like receptor 4 (TLR4)-PI3K-CDC42 pathway, thereby inhibiting the nuclear factor-kappa B (NF-κB) pathway, and consequently regulating phagocytosis and the inflammatory response. Our findings suggest that BBR might serve as a candidate for the development of phagocytic inhibitors.

Keywords

Berberine / Phagocytosis / TLR4-PI3K-CDC42

References

[1] Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al.: Incidence, Prevalence, and Co-occurrence of Autoimmune Disorders Over Time and By Age, Sex, and Socioeconomic Status: A Population-based Cohort Study of 22 Million Individuals in the UK. Lancet (London, England) 2023, 401: 1878-1890.

[2] Kourtzelis I, Hajishengallis G, Chavakis T: Phagocytosis of Apoptotic Cells in Resolution of Inflammation. Frontiers in Immunology 2020, 11: 553.

[3] Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al.: Macrophage Plasticity, Polarization, and Function in Health and Disease. Journal of Cellular Physiology 2018, 233: 6425-6440.

[4] Gonzalez MA, Lu DR, Yousefi M, Kroll A, Lo CH, Briseño CG, et al.: Phagocytosis Increases an Oxidative Metabolic and Immune Suppressive Signature in Tumor Macrophages. Journal of Experimental Medicine 2023, 220: e20221472.

[5] Galloway DA, Phillips AEM, Owen DRJ, Moore CS: Phagocytosis in the Brain: Homeostasis and Disease. Frontiers in Immunology 2019, 10: 790.

[6] Lu J, Gao X, Wang S, He Y, Ma X, Zhang T, et al.: Advanced Strategies to Evade the Mononuclear Phagocyte System Clearance of Nanomaterials. Exploration (Beijing, China) 2023, 3: 20220045.

[7] Campagno KE, Mitchell CH: The P₂X₇ Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis . Frontiers in Cellular Neuroscience 2021, 15: 645244.

[8] Iyori M, Kataoka H, Shamsul HM, Kiura K, Yasuda M, Nakata T, et al.: Resveratrol Modulates Phagocytosis of Bacteria Through an NF-kappaB-Dependent Gene Program. Antimicrobial Agents and Chemotherapy 2008, 52: 121-127.

[9] Cai Q, Li Y, Pei G: Polysaccharides from Ganoderma lucidum Attenuate Microglia-mediated Neuroinflammation and Modulate Microglial Phagocytosis and Behavioural Response. Journal of Neuroinflammation 2017, 14: 63.

[10] Wang K, Feng X, Chai L, Cao S, Qiu F: The Metabolism of Berberine and its Contribution to the Pharmacological Effects. Drug Metabolism Reviews 2017, 49: 139-157.

[11] Miao J, Ye P, Lan J, Ye S, Zhong J, Gresham A, et al.: Paeonol Promotes the Phagocytic Ability of Macrophages Through Confining HMGB1 to the Nucleus. International Immunopharmacology 2020, 89: 107068.

[12] Wang X, Cai H, Chen Z, Zhang Y, Wu M, Xu X, et al.: Baicalein Alleviates Pyroptosis and Inflammation in Hyperlipidemic Pancreatitis by Inhibiting NLRP3/Caspase-1 Pathway Through the miR-192-5p/TXNIP Axis. International Immunopharmacology 2021, 101: 108315.

[13] Wufuer R, Bai J, Liu Z, Zhou K, Taoerdahong H: Biological Activity of Brassica rapa L. Polysaccharides on RAW264.7 Macrophages and on Tumor Cells. Bioorganic & Medicinal Chemistry 2020, 28: 115330.

[14] Yang L, Xu H, Hong Q, Xu N, Zhang Y, Tao R, et al.: Crocus sativus L. Produces Anti-inflammatory Effects and Regulates the NLRP3-NF-κB Pathway. Acupuncture and Herbal Medicine 2024, 4: 375-385.

[15] Doherty GJ, McMahon HT: Mechanisms of Endocytosis. Annual Review of Biochemistry 2009, 78: 857-902.

[16] May RC, Machesky LM: Phagocytosis and the Actin Cytoskeleton. Journal of Cell Science 2001, 114: 1061-1077.

[17] Jubrail J, Kurian N, Niedergang F: Macrophage Phagocytosis Cracking the Defect Code in COPD. Biomedical Journal 2017, 40: 305-312.

[18] Onyishi CU, Desanti GE, Wilkinson AL, Lara-Reyna S, Frickel EM, Fejer G, et al.: Toll-like Receptor 4 and Macrophage Scavenger Receptor 1 Crosstalk Regulates Phagocytosis of a Fungal Pathogen. Nature Communications 2023, 14: 4895.

[19] Nobes CD, Hall A: Rho, rac, and cdc42 GTPases Regulate the Assembly of Multimolecular Focal Complexes Associated with Actin Stress Fibers, Lamellipodia, and Filopodia. Cell 1995, 81: 53-62.

[20] Hall A, Nobes CD: Rho GTPases: Molecular Switches that Control the Organization and Dynamics of the Actin Cytoskeleton. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2000, 355: 965-970.

[21] Ding L, Zhang L, Kim M, Byzova T, Podrez E: Akt3 Kinase Suppresses Pinocytosis of Low-density Lipoprotein by Macrophages via a Novel WNK/SGK1/Cdc42 Protein Pathway. The Journal of Biological Chemistry 2017, 292: 9283-9293.

[22] Horsthemke M, Bachg AC, Groll K, Moyzio S, Müther B, Hemkemeyer SA, et al.: Multiple Roles of Filopodial Dynamics in Particle Capture and Phagocytosis and Phenotypes of Cdc42 and Myo10 Deletion. The Journal of Biological Chemistry 2017, 292: 7258-7273.

[23] Cui H, Liu Y, Zheng Y, Li H, Zhang M, Wang X, et al.: Intelectin Enhances the Phagocytosis of Macrophages via CDC42-WASF2-ARPC2 Signaling Axis in Megalobrama amblycephala. International Journal of Biological Macromolecules 2023, 236: 124027.

[24] Rougerie P, Miskolci V, Cox D: Generation of Membrane Structures During Phagocytosis and Chemotaxis of Macrophages: Role and Regulation of the Actin Cytoskeleton. Immunological Reviews 2013, 256: 222-239.

[25] Rotty JD, Brighton HE, Craig SL, Asokan SB, Cheng N, Ting JP, et al.: Arp2/3 Complex is Required for Macrophage Integrin Functions but is Dispensable for FcR Phagocytosis and In Vivo Motility. Developmental Cell 2017, 42: 498-513.e6.

[26] Lu Y, Hsiang F, Chang JH, Yao XQ, Zhao H, Zou HY, et al.: Houshiheisan and its Components Promote Axon Regeneration After Ischemic Brain Injury. Neural Regeneration Research 2018, 13: 1195-1203.

[27] Ji X, Liu H, An C, Wang Y, Zhao H, Zhang Q, et al.: You-Gui Pills Promote Nerve Regeneration by Regulating netrin1, DCC and Rho Family GTPases RhoA, Racl, Cdc42 in C57BL/6 Mice with Experimental Autoimmune Encephalomyelitis. Journal of Ethnopharmacology 2016, 187: 123-133.

[28] Liu P, Jiang P, Yu Y, Tan K, Qin GY, Liu T, et al.: Modified Danzhi Xiaoyao Powder (MDXP) Improves the Corneal Damage in Dry Eye Disease (DED) Mice Through Phagocytosis. Journal of Ethnopharmacology 2024, 321: 117544.

[29] Wang S, Lu K, Lin L, Li G, Han Y, Lin Z, et al.: Exploring the Mechanism of Berberine Treatment for Atherosclerosis Combined with Non-alcoholic Fatty Liver Disease based on Bioinformatic and Experimental Study. PLoS One 2024, 19: e0314961.

[30] Ge N, Yan G, Sun H, Yang L, Kong L, Sun Y, et al.: Version Updates of Strategies for Drug Discovery Based on Effective Constituents of Traditional Chinese Medicine. Acupuncture and Herbal Medicine 2023, 3: 158-179.

[31] Shi M, Wei Y, Guo R, Luo F: Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis. Journal of Inflammation Research 2024, 17: 2285-2298.

[32] Zhang J, Liu J, Liu JW, Zhu QM, Zhang M, Zhang R, et al.: Targeting Keap1 with Inulae Herba Activated the Nrf2 Receptor to Alleviate LPS-mediated Acute Lung Injury. Journal of Ethnopharmacology 2024, 319: 117358.

[33] Zhang J, Zhang M, Huo XK, Ning J, Yu ZL, Morisseau C, et al.: Macrophage Inactivation by Small Molecule Wedelolactone via Targeting sEH for the Treatment of LPS-Induced Acute Lung Injury. ACS Central Science 2023, 9: 440-456.

[34] Li Y, Zhuang Q, Tao L, Zheng K, Chen S, Yang Y, et al.: Urolithin B Suppressed Osteoclast Activation and Reduced Bone Loss of Osteoporosis via Inhibiting ERK/NF-κB Pathway. Cell Proliferation 2022, 55: e13291.

[35] Ceasrine AM, Devlin BA, Bolton JL, Green LA, Jo YC, Huynh C, et al.: Maternal Diet Disrupts the Placenta-brain Axis in a Sex-specific Manner. Nature Metabolism 2022, 4: 1732-1745.

[36] Ma CH, Liu JP, Qu R, Ma SP: Tectorigenin Inhibits the Inflammation of LPS-induced Acute Lung Injury in Mice. Chinese Journal of Natural Medicines 2014, 12: 841-846.

[37] Nie Y, Huang M, Yang T, Mei Y, Zhang H, Wei X, et al.: Ferulic Acid Reduces Inflammatory Response Induced by Radiation Through Sirt1-NLRP3 Pathway. Acupuncture and Herbal Medicine 2024, 4: 367-374.

[38] Zhou S, Fan KK, Gu LF, Yu BY, Chai CZ: Anti-inflammatory Effects of Abelmoschus manihot (L.) Medik. on LPS-induced Cystitis in Mice: Potential Candidate for Cystitis Treatment Based on Classic Use. Chinese Journal of Natural Medicines 2022, 20: 321-331.

[39] Sun CP, Zhou JJ, Yu ZL, Huo XK, Zhang J, Morisseau C, et al.: Kurarinone Alleviated Parkinson’s Disease via Stabilization of Epoxyeicosatrienoic Acids in Animal Model. Proceedings of the National Academy of Sciences of the United States of America 2022, 119: e2118818119.

[40] Zhang J, Zhang M, Zhu QM, Xu XR, Feng YL, Lin S, et al.: Allosteric Regulation of Keap1 by 8β-hydroxy-α-Cyclocostunolide for the Treatment of Acute Lung Injury. Acta Pharmaceutica Sinica B 2024, 14: 4174-4178.

[41] Zhang J, Zhang WH, Morisseau C, Zhang M, Dong HJ, Zhu QM, et al.: Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Attenuated Particulate Matter 2.5 Exposure Mediated Lung Injury. Journal of Hazardous Materials 2023, 458: 131890.

[42] Zhang J, Luan ZL, Huo XK, Zhang M, Morisseau C, Sun CP, et al.: Direct Targeting of sEH with Alisol B Alleviated the Apoptosis, Inflammation, and Oxidative Stress in Cisplatin-induced Acute Kidney Injury. International Journal of Biological Sciences 2023, 19: 294-310.

[43] Zhu QM, Wang C, Liu JW, Zhang R, Xin XL, Zhang J, et al.: Degradation Profile of Environmental Pollutant 17β-Estradiol by Human Intestinal Fungus Aspergillus niger RG13B1 and Characterization of Genes Involved in its Degradation. Journal of Hazardous Materials 2024, 461: 132617.

[44] Li YL, Qin SY, Li Q, Song SJ, Xiao W, Yao GD: Jinzhen Oral Liquid Alleviates Lipopolysaccharide-induced Acute Lung Injury Through Modulating TLR4/MyD88/NF-κB Pathway. Phytomedicine 2023, 114: 154744.

[45] Brown GC: Cell Death by Phagocytosis. Nature Reviews Immunology 2024, 24: 91-102.

[46] Krendel M, Gauthier NC: Building the Phagocytic Cup On an Actin Scaffold. Current Opinion in Cell Biology 2022, 77: 102112.

[47] Herron JC, Hu S, Watanabe T, Nogueira AT, Liu B, Kern ME, et al.: Actin Nano-architecture of Phagocytic Podosomes. Nature Communications 2022, 13: 4363.

[48] Sliogeryte K, Botto L, Lee DA, Knight MM: Chondrocyte Dedifferentiation Increases Cell Stiffness by Strengthening Membrane-actin Adhesion. Osteoarthritis and Cartilage 2016, 24: 912-920.

[49] Jones PH, Okeoma CM: Phosphatidylinositol 3-Kinase is Involved in Toll-like Receptor 4-mediated BST-2/Tetherin Regulation. Cellular Signalling 2013, 25: 2752-2761.

[50] Mylvaganam S, Freeman SA, Grinstein S: The Cytoskeleton in Phagocytosis and Macropinocytosis. Current Biology 2021, 31: R619-R632.

[51] Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT: The PI3K Pathway in Human Disease. Cell 2017, 170: 605-635.

[52] Hao Y, Wu L, Wang Y, Shan D, Liu Y, Feng J, et al.: LPS Exacerbates TRPV4-mediated Itch Through the Intracellular TLR4-PI3K Signalling. Journal of Cellular and Molecular Medicine 2024, 28: e18509.

[53] Uribe-Querol E, Rosales C: Phagocytosis: Our Current Understanding of a Universal Biological Process. Frontiers in Immunology 2020, 11: 1066.

[54] Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, et al.: CD14 Controls the LPS-induced Endocytosis of Toll-like Receptor 4. Cell 2011, 147: 868-880.

[55] Rajaiah R, Perkins DJ, Ireland DD, Vogel SN: CD14 Dependence of TLR4 Endocytosis and TRIF Signaling Displays Ligand Specificity and is Dissociable in Endotoxin Tolerance. Proceedings of the National Academy of Sciences of the United States of America 2015, 112: 8391-8396.

[56] Xu Y, Zhong L, Liang Q, Xu H: New Perspective on the Treatment of Rheumatic Arthritis Based on “Strengthening Body Resistance (Fú Zhèng)” in the Theory of Co-inhibitory Receptor-regulated T-cell Immunity. Acupuncture and Herbal Medicine 2024, 4: 290-294.

[57] Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, et al.: TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron 2017, 95: 297-308.e6.

[58] Loriamini M, Lewis-Bakker MM, Frias Boligan K, Wang S, Holton MB, Kotra LP, et al.: Small Molecule Drugs That Inhibit Phagocytosis. Molecules 2023, 28: 757.

[59] Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, et al.: Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics 2019, 9: 1923-1951.

[60] Habtemariam S: Berberine Pharmacology and the Gut Microbiota: A Hidden Therapeutic Link. Pharmacological Research 2020, 155: 104722.

[61] Wang K, Yin J, Chen J, Ma J, Si H, Xia D: Inhibition of Inflammation by Berberine: Molecular Mechanism and Network Pharmacology Analysis. Phytomedicine 2024, 128: 155258.

[62] Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, et al.: Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules 2021, 26: 7368.

[63] Chen Y, Li K, Zhao H, Hao Z, Yang Y, Gao M, et al.: Integrated Lipidomics and Network Pharmacology Analysis to Reveal the Mechanisms of Berberine in the Treatment of Hyperlipidemia. Journal of Translational Medicine 2022, 20: 412.

[64] Qin Z, Tang R, Liang J, Jia X: Berberine, a Natural Alkaloid: Advances in its Pharmacological Effects and Mechanisms in the Treatment of Autoimmune Diseases. International Immunopharmacology 2024, 137: 112422.

[65] Dong Y, Fan H, Zhang Z, Jiang F, Li M, Zhou H, et al.: Berberine Ameliorates DSS-induced Intestinal Mucosal Barrier Dysfunction Through Microbiota-dependence and Wnt/β-catenin Pathway. International Journal of Biological Sciences 2022, 18: 1381-1397.

[66] Zhang S, Xu P, Zhu Z, Zhou L, Li J, Zhou R, et al.: Acetylation of p65^Lys310 by p300 in Macrophages Mediates Anti-inflammatory Property of Berberine . Redox Biology 2023, 62: 102704.

[67] Cockram TOJ, Dundee JM, Popescu AS, Brown GC: The Phagocytic Code Regulating Phagocytosis of Mammalian Cells. Frontiers in Immunology 2021, 12: 629979.

[68] Zhang F, Southwick FS, Purich DL: Actin-based Phagosome Motility. Cell Motility and the Cytoskeleton 2002, 53: 81-88.

[69] Ren Z, Yang H, Zhu C, Fan D, Deng J: Dietary Phytochemicals: As a Potential Natural Source for Treatment of Alzheimer’s Disease. Food Innovation and Advances 2023, 2: 36-43.

[70] Mukai T, Di Martino E, Tsuji S, Blomgren K, Nagamura-Inoue T, Ådén U, et al.: Umbilical Cord-derived Mesenchymal Stromal Cells Immunomodulate and Restore Actin Dynamics and Phagocytosis of LPS-activated Microglia via PI3K/Akt/Rho GTPase Pathway. Cell Death Discovery 2021, 7: 46.

[71] Fessler MB, Arndt PG, Frasch SC, Lieber JG, Johnson CA, Murphy RC, et al.: Lipid Rafts Regulate Lipopolysaccharide-induced Activation of Cdc42 and Inflammatory Functions of the Human Neutrophil. The Journal of Biological Chemistry 2004, 279: 39989-39998.